Prostate Cancer Clinical Trials in High Point, NC

Prostate Cancer Clinical Trials in High Point, NC

View the best 10 prostate cancer medical studies in High Point, North Carolina. Access promising new therapies by applying to a High Point-based Prostate Cancer clinical trial.

Trials in High Point, North Carolina

Here are the top 10 medical studies for prostate cancer in High Point, North Carolina

Image of Mayo Clinic Hospital in Phoenix, United States.

ADT +1 More

Hormone Therapy

Recruiting1 awardPhase 3
This trial is researching if a combination of ADT and darolutamide can help men with prostate cancer at high risk of biochemical recurrence (BCR) live longer without their cancer getting worse.
Image of University of Alabama at Birmingham in Birmingham, United States.

Enzalutamide +1 More

Antiandrogen

Recruiting1 awardPhase 3
This trial will test whether adding the drug enzalutamide to leuprolide helps patients with high-risk prostate cancer that has come back after surgery or radiotherapy.
Image of City of Hope National Medical Center in Duarte, United States.

AMG 509

Protein Kinase Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug called AMG 509 in adults to see if it is safe and to find the best dose. The study will monitor how people react to different doses.
Image of JHU Sidney Kimmel Comprehensive Cancer Center LAO in Baltimore, United States.

Lutetium Lu 177 Dotatate

Radioactive Drug

Recruiting1 awardPhase 2
This trial studies how well lutetium Lu 177 dotatate works in treating patients with a specific type of prostate cancer that has spread. The drug targets cancer cells and releases radiation to kill them. Lutetium-177 (Lu-177) PSMA therapy is a targeted treatment for advanced prostate cancer that has shown promising results.
Image of Rocky Mountain Regional VA Medical Center, Aurora, CO in Aurora, United States.

High dose testosterone

Hormone Therapy

Recruiting3 awardsPhase 2
This trial will test whether intermittent high-dose testosterone therapy can shrink tumors in men with DNA repair deficiency.
Image of Baptist M&S Imaging (Medical Center) in San Antonio, United States.

PF-06821497

Epigenetic Modulator

Recruiting2 awardsPhase 3
"This trial is testing if combining PF-06821497 with enzalutamide is safe and effective for treating metastatic castration-resistant prostate cancer. The main goal is to see if this combination
Image of Memorial Sloan Kettering Cancer Center in New York, United States.

LY4101174

Monoclonal Antibodies

Recruiting1 awardPhase 1
"This trial is testing a new drug called LY4101174 to see if it is safe and effective for people with advanced solid tumors. The trial has two parts and will take about 4 years to
Image of University of Minnesota Medical Center Fairview in Minneapolis, United States.

Xaluritamig

Hormone Therapy

Recruiting1 awardPhase 1
"This trial aims to see if xaluritamig is safe and well-tolerated when used alone in adults with a specific type of prostate cancer that has a high risk of coming back after
Image of Yale University- Yale Cancer Center in New Haven, United States.

Docetaxel +1 More

Cytotoxic Chemotherapy Agent

Recruiting2 awardsPhase 3
This trial is comparing the efficacy of adding Radium-223 to Docetaxel chemotherapy versus Docetaxel chemotherapy alone in men with metastatic hormone-refractory prostate cancer.
Image of USC Norris Comprehensive Cancer Center in Los Angeles, United States.

PC14586 +1 More

Small Molecule

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.